LLY | Eli Lilly

297.01 -6.24 (-2.06%)

LLY Price Profile

Open

$300.16

CLOSE

$297.01

DAY RANGE

296.87 - 301.66

52 WEEK RANGE

217.00 - 324.08

MARKET CAP

227.53B

Trading volume

786.9K

Prev. Close

303.25

50 Day MA

257.89

Shares Outstanding

956.59M

Public Float

904.82M

Average Volume

3.35M

Beta

0.36

PEG Ratio

5.20

Shares Shorted

6.19M

% OF SHARES SHORTED

0.78%

Short Ratio

1.80

1 Year Performance

0.00%

Diluted EPS (TTM)

6.55

Q Revenue Growth

0.18

Ebitda

9.66B

Gross Profit (TTM)

19.06B

Total Cash (MRQ)

3.85B

Total Debt (MRQ)

17.14B

  • MRQ = Most Recent Quarter.
  • TTM = Trailing Twelve Months.

Eli Lilly (LLY) company profile

Eli Lilly and Company (NYSE:LLY) is a drug manufacturing company for humans and animals. The company engages in discovering, developing, manufacturing, and selling pharmaceutical products. Its products include Diabetes and other endocrinology products like Baqsimi, Basaglar, Forteo, Humalog, Humatrope, Humulin, Jardiance, Trajenta and Trulicity. The company manufactures and sells its products through facilities in the United States, Puerto Rico, and eight other countries with production in about approximately 120 countries.

AD